منابع مشابه
A new hypothesis for dystonia.
In this issue of the Annals, Goto and colleagues present a new hypothesis concerning the pathophysiology of dystonia. A measure of our limited understanding of dystonias is the fact that although dystonia is a brain disorder, the most effective treatment is botulinum toxin chemodenervation at the neuromuscular junction. Ignorance of the mechanisms of dystonia is an obstacle to developing mechan...
متن کاملNew perspectives on dystonia.
Dystonia is a syndrome of sustained muscular contractions with numerous underlying etiologies. This review examines the varied phenomenology of dystonias, its evolving classification including recent genetic data as well as its clinical investigation and treatment. Although age of onset, anatomical distribution and family history are key elements of the investigation of dystonia, classification...
متن کاملTraditional Persian topical medications for gastrointestinal diseases
Drug delivery across the skin is used for several millennia to ease gastrointestinal (GI) ailments in Traditional Persian Medicine (TPM). TPM topical remedies are generally being applied on the stomach, lower abdomen, lower back and liver to alleviate GI illnesses such as dyspepsia, gastritis, GI ulcers, inflammatory bowel disease, intestinal worms and infections. The aim of the present study i...
متن کاملComplications of New Medications
Numerous mandibular pathologies are diagnosed in the emergency department (ED). We present the case of a woman with severe right-sided mandibular pain who was found to have a pathological fracture and osteonecrosis of the jaw (ONJ). The etiology of ONJ was found to be associated to previous use of zoledronic acid to treat osteoporosis. The aim of this case report is to discuss the etiology, dia...
متن کاملResponse: Anticipating New Medications
Lawrence DeMarzo: My agency, House of the Crossroads, like other drug-free com munity-based agencies, has historically cho sen not to use medications in its treatment regimens. That is changing now, through our involvement in NIDA’s Clinical Trials Network and our acquaintance with litera ture like Dr. Kampman’s article (Kampman, 2008). Much has changed since we started Cross roads. We know...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rinsho Shinkeigaku
سال: 2012
ISSN: 0009-918X,1882-0654
DOI: 10.5692/clinicalneurol.52.1074